Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Circadian rhythm, acute caffeine intake and exercise performance
IRCT20231004059615N2Phase 3Completed
- Sponsor
- International Science and Technology University
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of caffeine in obesity and cardiac morbidity, sponsored by International Science and Technology University. Primary endpoints: Exercise performance, Homeostatic responses and 1 more. Started Mar 2025; status: completed.
02
Drugs
caffeine
03
Conditions
obesitycardiac morbidity
Beyond the preview
Go deeper on IRCT20231004059615N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231004059615N2.